The case of two devices: disclosure to subjects following Phase IV ("post-marketing") research.
D008192:Deception; D030881:Disclosure; D004345:Drug Industry; D004864:Equipment and Supplies; D026724:Ethical Review; D004989:Ethics; D017041:Ethics Committees; D028744:Ethics Committees, Research; D035082:Federal Government; D005610:Freedom; D006076:Government; D033161:Government Regulation; D006805:Human Experimentation; D006801:Humans; D007258:Informed Consent; D033182:Intention; D009042:Motivation; D016134:Organizational Policy; D026684:Personal Autonomy; D004364:Pharmaceutical Preparations; D011897:Random Allocation; D035842:Research Subjects; D012306:Risk; D018570:Risk Assessment; D012926:Social Control, Formal; D014481:United States
Biomedical and Behavioral Research